PAR 2.13% 24.0¢ paradigm biopharmaceuticals limited..

MOZZ Research - First Half 2021, page-43

  1. 74 Posts.
    lightbulb Created with Sketch. 11
    re Epiitalis

    see Clinicaltrials.gov
    the trial was listed but NOT evaluated by the FDA
    the sponsor is Vedic Life Sciences.
    the trials were done in nursing homes in Mumbai India.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.005(2.13%)
Mkt cap ! $82.20M
Open High Low Value Volume
24.0¢ 24.5¢ 23.0¢ $37.20K 157.0K

Buyers (Bids)

No. Vol. Price($)
2 5386 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 34937 7
View Market Depth
Last trade - 13.31pm 10/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.